Saturday, October 11, 2025 8:18:06 AM
IsoPet and RadioGel use the same hydrogel and isototope, it’s one platform, not three different products. The difference is who regulates it: IsoPet’s NRC (animals), RadioGel’s FDA (humans), and India’s DCGI. Same tech, different paperwork.
The FDA absolutely does care about animal data, every device or drug starts with it. Those IsoPet results and GLP dosimetry studies are exactly what support the IDE submission. That’s how it works.
And no, the FDA didn’t “reject” anything. They gave feedback, which happens in every IDE cycle. You fix it, resubmit, move forward — which is exactly what Vivos just did after the Feb meeting.
As for “doesn’t work safely” — the hydrogel’s been tested and proven to stay put and hold the isotope right where it’s needed. That’s the whole point.
Calling it a scam? Nah. You don’t spend years running GLP studies, building NRC supply chains, and setting up India trials just to “string people along.” That’s called doing the work.
Maybe learn the FDA process before labeling it.
$RDGL
The FDA absolutely does care about animal data, every device or drug starts with it. Those IsoPet results and GLP dosimetry studies are exactly what support the IDE submission. That’s how it works.
And no, the FDA didn’t “reject” anything. They gave feedback, which happens in every IDE cycle. You fix it, resubmit, move forward — which is exactly what Vivos just did after the Feb meeting.
As for “doesn’t work safely” — the hydrogel’s been tested and proven to stay put and hold the isotope right where it’s needed. That’s the whole point.
Calling it a scam? Nah. You don’t spend years running GLP studies, building NRC supply chains, and setting up India trials just to “string people along.” That’s called doing the work.
Maybe learn the FDA process before labeling it.
$RDGL
Know what you own, and know why you own it.
Recent RDGL News
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2025 09:14:29 PM
